HCA Healthcare's results for Q3 2026 (quarter ended Sep 30, 2026) come from the company's own earnings release, filed with the SEC on 2026-10-27. Everything below is taken from that filing; quotes are copied exactly. Company outlooks are the company's own.
At a glance
| Item | Value |
|---|---|
| Revenue (GAAP) | $19,849 million (+3.6% vs a year earlier) |
| Diluted EPS (GAAP) | $7.27 |
| Adjusted per-share figure (company's non-GAAP measure; FFO/AFFO for REITs) | $7.22 |
| Full-year guidance | Reaffirmed |
Guidance
HCA expects full-year 2026 results in the upper half of its July guidance ranges: revenues $77.0–79.5 billion, EPS $28.70–30.50.
Why this label: Ranges unchanged; company 'now believes' results will be in the upper half of guidance issued July 14, 2026 (toward the high end, rule 8).
| Metric | Period | New | Prior (as stated in the release) |
|---|---|---|---|
| revenues | FY2026 | $77.0–79.5 billion (upper half expected) | not stated |
| diluted EPS | FY2026 | $28.70–30.50 (upper half expected) | not stated |
| adjusted EBITDA | FY2026 | $15.4–16.1 billion (upper half expected) | not stated |
| position within guidance ranges | FY2026 | upper half of ranges issued July 14, 2026 | not stated |
From the release
Revenue: "Revenues in the third quarter of 2026 totaled $19.849 billion, compared to $19.161 billion in the third quarter of 2025."
Earnings per share: "Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earnings per share, as adjusted, increased 3.7 percent to $7.22 per diluted share"
revenues: "Revenues · $ · 77,000 · $ · 79,500"
diluted EPS: "Net income attributable to HCA Healthcare, Inc. · $ · 28.70 · $ · 30.50"
adjusted EBITDA: "Adjusted EBITDA (a) (b) · $ · 15,400 · $ · 16,100"
Quotes are copied from the filing; in table rows, cell borders are shown as “·”.
Key fact: Payer-mix shift to uninsured patients cut Q3 pretax income by an estimated $400 million
Source
HCA Healthcare earnings release (SEC filing), accession 0001193125-26-432665, filed 2026-10-27.
Part of the Q3 2026 Guidance Tracker. Educational only, not advice. Free weekly recap every Sunday: yieldterminalpro.com/newsletter.